← Home
Gilead Sciences 
Pharma / Pharma
👤 Insider Trades
| Date | Type | Name | A/D | Amount | Price | Security |
|---|---|---|---|---|---|---|
| 2025-04-25 | M-Exempt | Telman Deborah H officer: EVP, Corporate Affairs & GC |
D | 514 | Restricted Stock Unit | |
| 2025-04-15 | S-Sale | Dickinson Andrew D officer: Chief Financial Officer |
D | 2500 | 106.4 | Common Stock |
| 2025-03-17 | S-Sale | Dickinson Andrew D officer: Chief Financial Officer |
D | 2500 | 110.53 | Common Stock |
| 2025-03-12 | Wilfong Diane E. officer: Interim Corp Controller & CAO |
5403 | 79.5 | Non-qualified Stock Option (Right to Buy) | ||
| 2025-03-10 | ***** | ***** |
***** | ***** | ***** | ***** |
| 2025-03-10 | ***** | ***** |
***** | ***** | ***** | ***** |
| 2025-03-10 | ***** | ***** |
***** | ***** | ***** | ***** |
| 2025-03-10 | ***** | ***** |
***** | ***** | ***** | ***** |
| 2025-03-10 | ***** | ***** |
***** | ***** | ***** | ***** |
🏛️ Explore more insider trade data for Gilead Sciences!
Sign up for free or log in🔓 Unlock our free guide: "The Checklist Value Investor — A Smarter Way to Pick Stocks"